Role of neuropeptides in cardiomyopathies

Peptides

Volumn 61, Issue , 2014, Pages 1-6

  Dvorakova, Magdalena Chottova ^a   Kruzliak, Peter ^b   Rabkin, Simon W ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Calcitonin gene related peptide (CGRP); Cardiomyopathy; Neuropeptide Y (NPY); Neuropeptides; Pathophysiology; Vasoactive intestinal peptide (VIP)

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERMEDIN; NEUROPEPTIDE; NEUROPEPTIDE Y; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

CARDIOMYOPATHY; DIABETIC CARDIOMYOPATHY; DISEASE ASSOCIATION; GENE CONTROL; HEART FAILURE; HUMAN; INFECTIVE CARDIOMYOPATHY; INFLAMMATORY CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; PROTEIN FUNCTION; RESTRICTIVE CARDIOMYOPATHY; REVIEW; TAKOTSUBO CARDIOMYOPATHY; ANIMAL; CARDIOMYOPATHIES; GENE EXPRESSION REGULATION; HEART MUSCLE; METABOLISM; PATHOLOGY;

ANIMALS; CARDIOMYOPATHIES; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MYOCARDIUM; NEUROPEPTIDES;

EID: 84906923068     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2014.08.004     Document Type: Review

References (82)

1. J. Ako, K. Sudhir, H.M. Farouque, Y. Honda, and P.J. Fitzgerald Transient left ventricular dysfunction under severe stress: brain-heart relationship revisited Am J Med 119 2006 10 17
2. S. Ananda, Y. Wang, S. Zhu, R. Wang, X. Zhou, and L. Zhuo Role of neuropeptide Y and peroxisome proliferator-activated receptor gamma coactivator-1alpha in stress cardiomyopathy J Huazhong Univ Sci Technolog Med Sci 32 2012 823 828
3. M.R. Bristow, F.L. Anderson, J.D. Port, L. Skerl, R.E. Hershberger, and P. Larrabee Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy Circulation 84 1991 1024 1039
4. M. Chottova Dvorakova, S. Wiegand, M. Pesta, J. Slavikova, V. Grau, and J. Reischig Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetes Neuroscience 151 2008 1016 1028
5. S. Cormier-Regard, S.V. Nguyen, and W.C. Claycomb Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes J Biol Chem 273 1998 17787 17792
6. M.V. Correa, M.O. da Costa Rocha, G.R. de Sousa, M. do Carmo Pereira Nunes, K.J. Gollob, and W.O. Dutra Low levels of vasoactive intestinal peptide are associated with Chagas disease cardiomyopathy Hum Immunol 74 2013 1375 1381
7. M. D'Souza, M.A. Garza, M. Xie, J. Weinstock, Q. Xiang, and P. Robinson Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection J Parasitol 93 2007 1121 1127
8. M.C. Deeds, J.M. Anderson, A.S. Armstrong, D.A. Gastineau, H.J. Hiddinga, and A. Jahangir Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models Lab Anim 45 2011 131 140
9. H.M. Dehlin, and S.P. Levick Substance P in heart failure: the good and the bad Int J Cardiol 170 2014 270 277
10. H.M. Dehlin, E.J. Manteufel, A.L. Monroe, M.H. Reimer Jr., and S.P. Levick Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension Int J Cardiol 168 2013 4643 4651
11. M. Delgado, C. Abad, C. Martinez, M.G. Juarranz, A. Arranz, and R.P. Gomariz Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases J Mol Med (Berl) 80 2002 16 24
12. M. Dvorakova Cardioprotective role of the VIP signaling system Drug News Perspect 18 2005 387 391
13. M. Dvorakova, J. Kuncova, U. Pfeil, G. McGregor, J. Sviglerova, and J. Slavikova Cardiomyopathy in streptozotocin-induced diabetes involves intra-axonal accumulation of calcitionin gene-related peptide and altered expression of its receptor in rats Neuroscience 134 2005 51 58
14. M. Dvorakova, J. Slavikova, and W. Kummer Substance P receptor in normal and diabetic rat heart Physiol Res 2007 13P
15. M.C. Dvorakova, U. Pfeil, J. Kuncova, J. Sviglerova, G. Galvis, and G. Krasteva Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy Cell Tissue Res 323 2006 383 393
16. A. Ejaz, F.W. LoGerfo, K. Khabbaz, and L. Pradhan Expression of Neuropeptide Y, Substance P, and their receptors in the right atrium of diabetic patients Clin Transl Sci 4 2011 346 350
17. P. Elliott, B. Andersson, E. Arbustini, Z. Bilinska, F. Cecchi, and P. Charron Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 2008 270 276
18. A. Franco-Cereceda, and J.M. Lundberg Actions of calcitonin gene-related peptide and tachykinins in relation to the contractile effects of capsaicin in the guinea-pig and rat heart in vitro Naunyn Schmiedebergs Arch Pharmacol 337 1988 649 655
19. E. Grossman, and F.H. Messerli Diabetic and hypertensive heart disease Ann Intern Med 125 1996 304 310
20. R.J. Henning, and D.R. Sawmiller Vasoactive intestinal peptide: cardiovascular effects Cardiovasc Res 49 2001 27 37
21. T. Hirose, K. Totsune, N. Mori, R. Morimoto, M. Hashimoto, and Y. Nakashige Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure Eur J Heart Fail 10 2008 840 849
22. D. Holmes, M. Campbell, M. Harbinson, and D. Bell Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP Curr Protein Pept Sci 14 2013 294 329
23. D.J. Hosking, T. Bennett, and J.R. Hampton Diabetic autonomic neuropathy Diabetes 27 1978 1043 1055
24. A. Ilhan, S. Rasul, A. Dimitrov, A. Handisurya, W. Gartner, and S. Baumgartner-Parzer Plasma neuropeptide Y levels differ in distinct diabetic conditions Neuropeptides 44 2010 485 489
25. H. Ito, D. Bell, M. Tamamori, T. Nozato, T. Shimojo, and S. Adachi Calcitonin gene-related peptide (CGRP) and hypertrophy of cardiomyocytes Heart Vessels 1997 15 17 Suppl 12
26. R. Kalfin, N. Maulik, R.M. Engelman, G.A. Cordis, K. Milenov, and L. Kasakov Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium J Pharmacol Exp Ther 268 1994 952 958
27. G. Kallner Release and effects of calcitonin gene-related peptide in myocardial ischaemia Scand Cardiovasc J Suppl 49 1998 1 35
28. A.A. Kamal, S.S. Tay, and W.C. Wong The cardiac ganglia in streptozotocin-induced diabetic rats Arch Histol Cytol 54 1991 41 49
29. C. Kumaran, and K. Shivakumar Calcium- and superoxide anion-mediated mitogenic action of substance P on cardiac fibroblasts Am J Physiol Heart Circ Physiol 282 2002 H1855 H1862
30. J. Kuncova, J. Sviglerova, Z. Tonar, and J. Slavikova Heterogenous changes in neuropeptide Y, norepinephrine and epinephrine concentrations in the hearts of diabetic rats Auton Neurosci 121 2005 7 15
31. T. Kunt, T. Forst, S. Schmidt, A. Pfutzner, S. Schneider, and O. Harzer Serum levels of substance P are decreased in patients with type 1 diabetes Exp Clin Endocrinol Diabetes 108 2000 164 167
32. P. Lechleitner, N. Genser, J. Mair, A. Dienstl, C. Haring, and C.J. Wiedermann Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction Am Heart J 124 1992 1433 1439
33. S.P. Levick, D.B. Murray, J.S. Janicki, and G.L. Brower Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart Hypertension 55 2010 270 276
34. Y.J. Li, Z.S. Xiao, C.F. Peng, and H.W. Deng Calcitonin gene-related peptide-induced preconditioning protects against ischemia-reperfusion injury in isolated rat hearts Eur J Pharmacol 311 1996 163 167
35. N. Liu, L.Z. Zhang, Y. Han, and Z. Guo Differential effects of the calcitonin gene-related peptide on cardiac performance in acute myocardial ischemia and reperfusion in isolated rat hearts Minerva Anestesiol 77 2011 789 796
36. R.E. Lopes, and W.L. Tafuri Involvement of the autonomic nervous system in Chagas heart disease Revista da Sociedade Brasileira de Medicina Tropical 16 1983 206 212
37. R. Lu, C.P. Hu, J. Peng, H.W. Deng, and Y.J. Li Role of calcitonin gene-related peptide in ischaemic preconditioning in diabetic rat hearts Clin Exp Pharmacol Physiol 28 2001 392 396
38. B. Maisch, M. Noutsias, V. Ruppert, A. Richter, and S. Pankuweit Cardiomyopathies: classification, diagnosis, and treatment Heart Fail Clin 8 2012 53 78
39. B. Maisch, and S. Pankuweit Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy Herz 37 2012 644 656
40. B.J. Maron, J.A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, and D. Arnett Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
41. R. Matyal, F. Mahmood, M. Robich, H. Glazer, K. Khabbaz, and P. Hess Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue Eur J Pharmacol 665 2011 19 28
42. R. Matyal, S. Sakamuri, A. Wang, E. Mahmood, M.P. Robich, and K. Khabbaz Local infiltration of neuropeptide Y as a potential therapeutic agent against apoptosis and fibrosis in a swine model of hypercholesterolemia and chronic myocardial ischemia Eur J Pharmacol 718 2013 261 270
43. G.C. Melendez, J. Li, B.A. Law, J.S. Janicki, S.C. Supowit, and S.P. Levick Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells Cardiovasc Res 92 2011 420 429
44. T. Miki, S. Yuda, H. Kouzu, and T. Miura Diabetic cardiomyopathy: pathophysiology and clinical features Heart Fail Rev 18 2013 149 166
45. E. Mistrova, S. Wiegand, J. Sviglerova, U. Pfeil, J. Kuncova, and J. Slavikova Adrenomedullin and the calcitonin receptor-like receptor system mRNA expressions in the rat heart and sensory ganglia in experimentally-induced long-term diabetes Gen Physiol Biophys 33 2014 215 225
46. T. Miyauchi, T. Ishikawa, Y. Sugishita, A. Saito, and K. Goto Effects of capsaicin on nonadrenergic noncholinergic nerves in the guinea pig atria: role of calcitonin gene-related peptide as cardiac neurotransmitter J Cardiovasc Pharmacol 10 1987 675 682
47. B.R. Nascimento, C.G. Araujo, M.O. Rocha, J.D. Domingues, A.B. Rodrigues, and M.V. Barros The prognostic significance of electrocardiographic changes in Chagas disease J Electrocardiol 45 2012 43 48
48. R.D. Nascimento, P.R. Martins, A. de Souza Lisboa, S.J. Adad, A.B. Morais da Silveira, and D. Reis An imbalance between substance P and vasoactive intestinal polypeptide might contribute to the immunopathology of megaesophagus after Trypanosoma cruzi infection Hum Pathol 44 2013 269 276
49. H.M. Nef, H. Mollmann, P. Hilpert, F. Masseli, S. Kostin, and C. Troidl Sympathoadrenergic overstimulation in Tako-Tsubo cardiomyopathy triggered by physical and emotional stress Int J Cardiol 130 2008 226 228
50. E. Oie, L.E. Vinge, A. Yndestad, C. Sandberg, H.K. Grøgaard, and H. Attramadal Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats Circulation 101 2000 415 422
51. N.M. Page Characterization of the gene structures, precursor processing and pharmacology of the endokinin peptides Vascul Pharmacol 45 2006 200 208
52. J. Pons, E.W. Lee, L. Li, and J. Kitlinska Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases Curr Opin Investig Drugs 5 2004 957 962
53. B. Racz, B. Gasz, F. Gallyas Jr., P. Kiss, A. Tamas, and Z. Szanto PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis Regul Pept 145 2008 105 115
54. P. Richardson, W. McKenna, M. Bristow, B. Maisch, B. Mautner, and J. O'Connell Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies Circulation 93 1996 841 842
55. P. Robinson, A. Garza, J. Moore, T.K. Eckols, S. Parti, and V. Balaji Substance P is required for the pathogenesis of EMCV infection in mice Int J Clin Exp Med 2 2009 76 86
56. J. Roh, C.L. Chang, A. Bhalla, C. Klein, and S.Y. Hsu Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes J Biol Chem 279 2004 7264 7274
57. R.J. Sanchez Torres, and R. Calderon The cardiomyopathies, a review for the primary physician P R Health Sci J 23 2004 285 292
58. H. Sano, A. Miyata, T. Horio, T. Nishikimi, H. Matsuo, and K. Kangawa The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor Regul Pept 109 2002 107 113
59. S. Sapna, K. Shivakumar, and P. Substance enhances soluble ICAM-1 release from adult rat cardiac fibroblasts by a p42/44 MAPK- and PKC-mediated mechanism Cell Biol Int 31 2007 856 859
60. C. Satoh, F. Satoh, K. Takahashi, O. Murakami, M. Sone, and K. Totsune Elevated plasma immunoreactive neuropeptide Y concentrations and its increased urinary excretion in patients with advanced diabetic nephropathy Endocr J 46 1999 139 146
61. M. Schumer, G. Burton, C. Burton, D. Crum, and M.A. Pfeifer Diabetic autonomic neuropathy - Part I. Autonomic nervous system data analysis by a computerized central unit in a multicenter trial Am J Med 85 1988 137 143
62. J. Shanks, and N. Herring Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides Am J Physiol Regul Integr Comp Physiol 305 2013 R1411 R1420
63. S.A. Shawket, and M.J. Brown Pathogenetic and therapeutic implications of calcitonin-gene-related peptide in the cardiovascular system Trends Cardiovasc Med 1 1991 211 215
64. N.M. Smulders, A. Bast, M.J. van Kroonenburgh, and M. Drent Improvement of cardiac sympathetic nerve function in sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 25 2008 140 142
65. S. Sugo, N. Minamino, K. Kangawa, K. Miyamoto, K. Kitamura, and J. Sakata Endothelial cells actively synthesize and secrete adrenomedullin Biochem Biophys Res Commun 201 1994 1160 1166
66. S. Szardien, H. Mollmann, S. Voss, C. Troidl, A. Rolf, and C. Liebetrau Elevated serum levels of neuropeptide Y in stress cardiomyopathy Int J Cardiol Netherlands 147 2011 155 157
67. A.M. Szema, S.A. Hamidi, S.D. Smith, and H. Benveniste VIP gene deletion in mice causes cardiomyopathy associated with upregulation of heart failure genes PLoS One 8 2013 e61449
68. Y. Takei, K. Inoue, M. Ogoshi, T. Kawahara, H. Bannai, and S. Miyano Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator FEBS Lett 556 2004 53 58
69. X. Wang, and R.R. Fiscus Calcitonin gene-related peptide increases cAMP, tension, and rate in rat atria Am J Physiol 256 1989 R421 R428
70. Y. Wang, M. Shimada, Y. Xu, D. Hu, R. Nishio, and A. Matsumori Role of substance P in viral myocarditis in mice Heart Vessels 25 2010 348 352
71. K. Yalta, N. Sivri, and T. Yalta Neuropeptide Y-induced coronary microvascular dysfunction: a significant contributor to the adverse outcomes in stress cardiomyopathy? Int J Cardiol Netherlands 2011 284
72. J.H. Yang, Y.X. Jia, C.S. Pan, J. Zhao, M. Ouyang, and J. Yang Effects of intermedin(1-53) on cardiac function and ischemia/reperfusion injury in isolated rat hearts Biochem Biophys Res Commun 327 2005 713 719
73. J.H. Yang, C.G. Ma, Y. Cai, C.S. Pan, J. Zhao, and C.S. Tang Effect of intermedin1-53 on angiotensin II-induced hypertrophy in neonatal rat ventricular myocytes J Cardiovasc Pharmacol 56 2010 45 52
74. X. Yang, H. Zhang, Y. Jia, L. Ni, G. Li, and L. Xue Effects of intermedin1-53 on myocardial fibrosis Acta Biochim Biophys Sin (Shanghai) 45 2013 141 148
75. V.Z. Ye, G. Hodge, J.L. Yong, and K.A. Duggan Early myocardial fibrosis is associated with depletion of vasoactive intestinal peptide in rat heart Exp Physiol 87 2002 539 546
76. V.Z. Ye, G. Hodge, J.L. Yong, and K.A. Duggan Vasopeptidase inhibition reverses myocardial vasoactive intestinal peptide depletion and decreases fibrosis in salt sensitive hypertension Eur J Pharmacol 485 2004 235 242
77. H. Yin, L. Chao, and J. Chao Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling Hypertension 43 2004 109 116
78. S.W. Zarich, and R.W. Nesto Diabetic cardiomyopathy Am Heart J 118 1989 1000 1012
79. H.Y. Zhang, W. Jiang, J.Y. Liu, Y. Li, C.L. Chen, and H.B. Xin Intermedin is upregulated and has protective roles in a mouse ischemia/reperfusion model Hypertens Res 32 2009 861 868
80. M. Dvorakova Cardiomyopathy in streptozotocin-induced diabetes involves intra-axonal accumulation of calcitionin gene-related peptide and altered expression of its receptor in ats Neuroscience 134 2005 51 58
81. A. Milewicz, B. Bidzinska, E. Mikulski, M. Demissie, and U. Tworowska Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels Gynecol Endocrinol 14 2000 196 203
82. H. Mori, T. Nakamachi, H. Ohtaki, S. Yofu, A. Sato, and K. Endo Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on Doxorubicin-induced cardiomyopathy in mice Circ J 74 6 2010 1183 1190